Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;137(3):868-78.
doi: 10.1016/j.jaci.2015.07.048. Epub 2015 Oct 6.

Risk of anaphylaxis after vaccination in children and adults

Michael M McNeil  1 , Eric S Weintraub  2 , Jonathan Duffy  2 , Lakshmi Sukumaran  2 , Steven J Jacobsen  3 , Nicola P Klein  4 , Simon J Hambidge  5 , Grace M Lee  6 , Lisa A Jackson  7 , Stephanie A Irving  8 , Jennifer P King  9 , Elyse O Kharbanda  10 , Robert A Bednarczyk  11 , Frank DeStefano  2
Affiliations

Risk of anaphylaxis after vaccination in children and adults

Michael M McNeil et al. J Allergy Clin Immunol. 2016 Mar.

Abstract

Background: Anaphylaxis is a potentially life-threatening allergic reaction. The risk of anaphylaxis after vaccination has not been well described in adults or with newer vaccines in children.

Objective: We sought to estimate the incidence of anaphylaxis after vaccines and describe the demographic and clinical characteristics of confirmed cases of anaphylaxis.

Methods: Using health care data from the Vaccine Safety Datalink, we determined rates of anaphylaxis after vaccination in children and adults. We first identified all patients with a vaccination record from January 2009 through December 2011 and used diagnostic and procedure codes to identify potential anaphylaxis cases. Medical records of potential cases were reviewed. Confirmed cases met the Brighton Collaboration definition for anaphylaxis and had to be determined to be vaccine triggered. We calculated the incidence of anaphylaxis after all vaccines combined and for selected individual vaccines.

Results: We identified 33 confirmed vaccine-triggered anaphylaxis cases that occurred after 25,173,965 vaccine doses. The rate of anaphylaxis was 1.31 (95% CI, 0.90-1.84) per million vaccine doses. The incidence did not vary significantly by age, and there was a nonsignificant female predominance. Vaccine-specific rates included 1.35 (95% CI, 0.65-2.47) per million doses for inactivated trivalent influenza vaccine (10 cases, 7,434,628 doses given alone) and 1.83 (95% CI, 0.22-6.63) per million doses for inactivated monovalent influenza vaccine (2 cases, 1,090,279 doses given alone). The onset of symptoms among cases was within 30 minutes (8 cases), 30 to less than 120 minutes (8 cases), 2 to less than 4 hours (10 cases), 4 to 8 hours (2 cases), the next day (1 case), and not documented (4 cases).

Conclusion: Anaphylaxis after vaccination is rare in all age groups. Despite its rarity, anaphylaxis is a potentially life-threatening medical emergency that vaccine providers need to be prepared to treat.

Keywords: Anaphylaxis; immunization; vaccine safety.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Search strategy for anaphylaxis cases, 2009-2011.
See this image and copyright information in PMC

References

    1. Austen KF. Disease of immediate type hypersensitivity. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, editors. Harrison’s principles of internal medicine. 13th McGraw-Hill; New York: 1994. pp. 1630–8.
    1. Simmons FE. Anaphylaxis. J Allergy Immunol. 2010;125(suppl):S161–81. - PubMed
    1. Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, Lang DM, Bernstein DI, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol. 2010;126:477–80. e1-42. - PubMed
    1. Simons FE, Ardusso LR, Bilo B, El-Gamal YM, Ledford DK, Ring J, et al. World Allergy Organization guidelines for the assessment and management of anaphylaxis. J Allergy Clin Immunol. 2011;127(593):e1–22. - PMC - PubMed
    1. Centers for Disease Control and Prevention General recommendations on immunization—recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2011;60:1–64. - PubMed

Publication types